IS THERE A RATIONAL MANAGEMENT STRATEGY FOR TARDIVE DYSKINESIA?

The authors of “Is there a rational management strategy for tardive dyskinesia” emphasize the importance of preventing tardive dyskinesia via conservative dosing and routine movement disorder assessment. They also propose a management treatment algorithm for treatment of confirmed tardive dyskinesia.

A reminder that a special subscription price is available to Current Psychiatry, a monthly peer-reviewed publication, and the leading source of practical, evidence-based information for healthcare professionals treating psychiatric patients. Thanks to the CPNP partnership with Current Psychiatry, CPNP members can receive a year of Current Psychiatry at a cost of $24, over 77% less than the normal subscription rate.

2012 ANNUAL MEETING PRE-MEETING WORKSHOP PREVIEW

CPNP's 2011 Annual Meeting keynote speaker Linda Strand, PharmD, PhD, provided a motivating, can-do view of healthcare reform legislation and the opportunities available to pharmacists. This quarter's complimentary CPNP University member product, Seizing the MTM Opportunity: What Psychiatric Pharmacists Need To Know, is a recording of that session available for 1 hour of ACPE credit.

Strand (back by popular demand) rejoins us at the 2012 CPNP Annual Meeting offering her popular day-long, hands-on MTM Boot Camp focused on growing your role as a neuropsychiatric pharmacist within the new health care system.

CPNP Pre-Meeting Workshop: MTM Boot Camp The Business of Patient Care: Incorporating Comprehensive Medication Management (MTM) into your Practice

Sunday, April 29, 7:30 a.m.–11:15 a.m. and 1:30–5:15 p.m.

Tampa Marriott Waterside, Tampa, Florida

ACPE and CME Approved for 7.0 Contact Hours (Application Level Programming)

Beginning with an update on the health care system, the emphasis will be on the role of the pharmacist in the new organizational structures of the medical home and accountable care organizations. The program will detail what payers want from pharmacists who wish to provide medication management services. Keys to defining your service, recruiting patients, demonstrating your value, charging for your services and expanding your service will all be demonstrated.

This workshop will provide critical information to pharmacists in all practice settings. You will get important questions answered and understand what changes are needed to achieve and maintain a successful practice. You will also have the opportunity to learn from individuals in the private sector who have experience in delivering medication management services. Join us with the goal of making your service even more successful in 2012.

LAST CHANCE FOR ABSTRACT SUBMISSION FOR 2012 ANNUAL MEETING!

You can submit abstracts online for the 2012 CPNP Annual Meeting through January 11, 2012. Accepted abstracts will be displayed at the poster session Sunday, April 29 or Monday, April 30 at the Tampa Marriott Waterside Hotel in Tampa, Florida. Presenting authors of accepted posters must be paid registrants for a minimum of the day of the poster session. The registration must be received by February 14, 2012, or the abstract will be administratively removed. The registration for the presenting author cannot be cancelled.

Abstracts may be submitted in one of five different categories:

• •Original Research

  Abstracts should describe original research in therapeutics, pharmacodynamics, pharmacoeconomics, outcomes, drug utilization, kinetics and genetics. Abstracts must not have been published in abstract form nor presented elsewhere before the CPNP 2012 Meeting.

• •Encore Presentation

  Abstracts that have been previously presented and peer reviewed. Submission must include where it was previously presented or the abstract will be disqualified. Encore submissions are not eligible for any of the award categories and should not be submitted for award consideration.

• •Work in Progress (WIP)

  Abstracts describing preliminary results or status of ongoing work may be submitted by principal investigators at any stage of their career. Abstracts submitted without results at the time of submission will be considered for this category only.

• •Innovative Practices

  Abstracts describing the development, justification, documentation, and/or delivery of innovative services or activities applicable to psychiatric and neurologic pharmacy. The descriptive abstract should not duplicate any other poster category and should describe the development of innovative services/activities and should provide background/rationale, a description of the innovative service, the impact on patient care/institution and a conclusion.

• •Therapeutic Case Report

  Abstracts describing the various aspects of pharmaceutical care relating to individual psychiatric and/or neurological pharmacy cases. Abstracts should provide a complete patient history including age, gender, time from first diagnosis, social background, and details of, and response to, previous and current treatment(s). Cases should include background, complete patient history, review of literature, and conclusion.

Abstracts may also be considered in one of five different award categories:

• •Research Trainee Award

• •New Investigator Award

• •Original Research

• •Innovative Practices Award

• •Therapeutic Case Report Award

Please note that for the Research Trainee category, Works in Progress are allowed, provided there is an interim data analysis and timetable for completion included in the abstract. Individuals who have completed a residency within the last 12 months are eligible for this award.

For more information, visit the abstract center online. It provides abstract examples, a database of prior years' abstracts, judging criteria, and other valuable resources as you prepare your abstract for submission. If you have any questions, please contact the CPNP office at